Oral Potentially Malignant Disorders among Dental Patients: a Pilot Study in Jordan

  • Hassona, Y. (Department of Oral Surgery, Oral Medicine and Periodontology, Faculty of Dentistry, The University of Jordan) ;
  • Scully, C. (University College London) ;
  • Almangush, A. (Department of Pathology, Haartman institute, University of Helsinki) ;
  • Baqain, Z. (Department of Oral Surgery, Oral Medicine and Periodontology, Faculty of Dentistry, The University of Jordan) ;
  • Sawair, F. (Department of Oral Surgery, Oral Medicine and Periodontology, Faculty of Dentistry, The University of Jordan)
  • Published : 2015.01.06


Background: To determine the prevalence, types, and risk factors of oral potentially malignant disorders (OPMDs) among a group of Arab Jordanian dental patients, and to evaluate their awareness and attitudes toward early diagnosis and treatment. Materials and Methods: A total of 1,041 patients attending a University Hospital for dental care were examined for the presence of OPMDs. Histopathological examination was performed on all cases clinically diagnosed and patients were directly interviewed to evaluate their knowledge and attitudes toward early detection and treatment of oral cancer. Results: The prevalence of OPMDs overall was 2.8%. Lichen planus/lichenoid lesions were the most common lesions (1.8%) followed by leukoplakias (0.48%), chronic hyperplastic candidiosis (0.38%), and erythroplakia (0.096%). Smoking, alcohol, and age (>40 years) were the main identifiable risk factors. Patients with OPMDs displayed a general lack of awareness and negative attitudes towards early diagnosis and treatment. Conclusions: OPMDs among Arab dental patients are relatively uncommon and awareness about oral cancer among Jordanian dental patients is low. Interventions to improve public knowledge about oral cancer and attitudes toward early diagnosis and treatment are urgently indicated.


Oral;potentially malignant;cancer;Arab;Jordan;early detection;precancer


  1. Al-Attas SA, Ibrahim SS, Amer HA, Darwish Zel-S, Hassan MH (2014). Prevalence of potentially malignant oral mucosal lesions among tobacco users in Jeddah, Saudi Arabia. Asian Pac J Cancer Prev, 15, 757-62.
  2. Alsanosy RM (2014). Smokeless tobacco (shammah) in Saudi Arabia: a review of its pattern of use, prevalence, and potential role in oral cancer. Asian Pac J Cancer Prev, 15, 6477-83.
  3. Amarasinghe AAHK, Usgodaarachchi US, Johnson NW, Lalloo R, Warnakulasuriya S (2010). Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: a case-control study. Oral Oncol, 46, 279-301.
  4. Angadi PV, Savitha JK, Rao SS, Sivaranjini Y (2012). Oral field cancerization: current evidence and future perspectives. Oral Maxillofac Surg, 16, 171-80.
  5. Arduino PG, Surace A, Carbone M, et al (2009). Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. J Oral Pathol Med, 38, 540-4.
  6. Axell T (1987). Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol, 15, 46-51.
  7. Axell T, Holmstrup P, Kramer IRH, Pindborg JJ, Shear M (1984). International seminar on oral leukoplakia and associated lesions related to tobacco habits. JOURNAL, 12, 145-54.
  8. Banoczy J, Rigo O (1991). Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol, 19, 265-7.
  9. Braakhuis BJ, Leemans CR, Brakenhoff RH (2004). A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med, 33, 317-22.
  10. Chung CH, Yang YH, Wang TY, Shieh TY, Warnakulasuriya S (2005). Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med, 34, 460-6.
  11. Garavello W, Lucenteforte E, Bosetti C, La Vecchia C (2009). The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol, 58, 25-34.
  12. Garcia-Pola Vallejo MJ, Martinez Diaz-Canel AI, Garcia Martin JM, Gonzalez Garcia M (2002). Risk factors for oral soft tissue lesions in an adult Spanish population. Community Dent Oral Epidemiol, 30, 277-85.
  13. Georgakopoulou EA, Achtari MD, Achtaris M, Foukas PG, Kotsinas A (2012). Oral lichen planus as a preneoplastic inflammatory model. J Biomed Biotechnol, 2012, 759626.
  14. Gupta PC, Bhonsle RB, Murti PR, et al (1998). An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer, 63, 2247-52.
  15. Hobbs CG, Sterne JA, Bailey M, et al (2006). Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol, 31, 259-66.
  16. Holmstrup P, Vedtofte P, Reibel J, Stoltze K (2006). Long-term treatment outcome of oral premalignant lesions. Oral Oncol, 42, 461-74.
  17. Ismail SI, Soubani M, Nimri JM, Al-Zeer AH (2013). Cancer incidence in Jordan from 1996 to 2009 - a comprehensive study. Asian Pac J Cancer Prev, 14, 3527-34.
  18. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
  19. Johnson NW, Jayasekara P, Amarasinghe AA (2011). Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol, 57, 19-37.
  20. Kramer IR, Pindborg JJ, Bezroukov V, Infirri JS (1980). Guide to epidemiology and diagnosis of oral mucosal diseases and conditions. world health organization. Community Dent Oral Epidemiol, 8, 1-26.
  21. Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R (2013). Epidemiology of oral cancer in Asia in the past decade-an update (2000-2012). Asian Pac J Cancer Prev, 14, 5567-77.
  22. Lodi G, Scully C, Carrozzo M, et al (2005). Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 100, 164-78.
  23. Marks MA, Chaturvedi AK, Kelsey K, et al (2014). Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium. Cancer Epidemiol Biomarkers Prev, 23, 160-71.
  24. Mini GK, Sarma PS, Thankappan KR (2014). Pattern of tobacco use and its correlates among older adults in India. Asian Pac J Cancer Prev, 15, 6195-8.
  25. Mehrotra R, Pandya S, Chaudhary AK, Kumar M, Singh M (2008). Prevalence of oral pre-malignant and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev, 9, 263-5.
  26. Moles DR, Fedele S, Speight PM, Porter SR, dos Santos Silva I (2008). Oral and pharyngeal cancer in South Asians and non-South Asians in relation to socioeconomic deprivation in South East England. Br J Cancer, 98, 633-5.
  27. Napier SS, Cowan CG, Gregg TA, et al (2003). Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis, 9, 129-37.
  28. Napier SS, Speight PM (2008). Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med, 37, 1-10.
  29. Nicolotti N, Chuang SC, Cadoni G, et al (2011). Recreational physical activity and risk of head and neck cancer: a pooled analysis within the international head and neck cancer epidemiology (INHANCE) Consortium. Eur J Epidemiol, 26, 619-28.
  30. Petti S, Mohd M, Scully C (2012). Revisiting the association between alcohol drinking and oral cancer in nonsmoking and betel quid non-chewing individuals. Cancer Epidemiol, 36, 1-6.
  31. Reibel J (2013). Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med, 14, 47-62.
  32. Reichart PA (2000). Oral mucosal lesions in a representative cross-sectional study of aging Germans. Community Dent Oral Epidemiol, 28, 390-8.
  33. Reichart PA, Philipsen HP (2005). Oral erythroplakia-a review. Oral Oncol, 41, 551-61.
  34. Schepman K, van der Meij EH, Smeele L, van der Waal I (1999). Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Disease, 5,206-9.
  35. Schepman KP, van der Meij EH, Smeele LE, van der Waal I (1996). Prevalence study of oral white lesions with special reference to a new definition of oral leucoplakia. Eur J Cancer B Oral Oncol, 32, 416-9.
  36. Scheifele C, Reichart PA, Dietrich T (2003). Low prevalence of oral leukoplakia in a representative sample of the US population. Oral Oncol, 39, 619-25.
  37. Scully C (2014). Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia. Oral Dis, 20, 1-5.
  38. Scully C. Rule for cancer diagnosis (2013). Br Dent J, 215, 265-6.
  39. Scully C, Bagan J (2009). Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis, 15, 388-99.
  40. Thomas SJ, Harris R, Ness AR, et al (2008). Betel quid not containing tobacco and oral leukoplakia: a report on a crosssectional study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer, 123, 1871-6.
  41. Sujatha D, Hebbar PB, Pai A (2012). Prevalence and correlation of oral lesions among tobacco smokers, tobacco chewers, areca nut and alcohol users. Asian Pac J Cancer Prev, 13, 1633-7.
  42. Turati F, Edefonti V, Bosetti C, et al (2013). Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncol, 24, 2651-6.
  43. van der Meij EH, Mast H, van der Waal I (2007). The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol, 43, 742-8.
  44. van der Waal I (2009). Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol, 45, 317-23.
  45. van Leeuwen MT, Grulich AE, McDonald SP, et al (2009). Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev, 18, 561-9.
  46. Warnakulasuriya S, Johnson NW, van der Waal I (2007). Nomenclature and classification of potentially malignant disorders of the oral mucosa, 36, 575-80.
  47. Warnakulasuriya S, Kovacevic T, Madden P, et al (2011). Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med, 40, 677-83.
  48. Zini A, Nasser N, Vered Y (2012). Oral and pharyngeal cancer among the Arab population in Israel from 1970 to 2006. Asian Pac J Cancer Prev, 13, 585-9.

Cited by

  1. Prevalence and clinical features of pigmented oral lesions vol.55, pp.9, 2015,
  2. Absence of high-risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disorders vol.13, pp.1, 2016,